TY  - JOUR
PY  - 2006//
TI  - Melatonin treatment in adolescents with delayed sleep phase syndrome
JO  - Clinical pediatrics
A1  - Szeinberg, Amir
A1  - Borodkin, Katy
A1  - Dagan, Yaron
SP  - 809
EP  - 818
VL  - 45
IS  - 9
N2  - This retrospective study describes the effects of long-term treatment with melatonin in 33 adolescents (age range, 10-18 years) with delayed sleep phase syndrome (DSPS). Patients were treated with oral melatonin, 3 to 5 mg/day for an average period of 6 months. During the treatment, sleep onset was advanced and sleep duration was longer. Treatment was also associated with a decrease in the proportion of patients reporting school difficulties. No adverse effects of melatonin were noted. This study indicates that long-term treatment with melatonin can be beneficial for adolescents with DSPS in terms of sleep-wake schedule and school performance.<p /> <p>Language: en</p>
LA  - en
SN  - 0009-9228
UR  - http://dx.doi.org/10.1177/0009922806294218
ID  - ref1
ER  -